K2 Principal Fund’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-52,416
Closed -$578K 434
2017
Q4
$578K Buy
+52,416
New +$505K 0.04% 227

K2 Principal Fund's MGCD Position: Q1 2018 in Review

K2 Principal Fund sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 52,416 shares — an estimated $578K sold.

K2 Principal Fund first reported a position in MGCD in Q4 2017 and held it in 1 quarter. The position peaked at $578K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.

  • K2 Principal Fund reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
  • K2 Principal Fund sold 52,416 MGC Diagnostics Corporation shares in Q1 2018, an estimated $578K.
  • K2 Principal Fund first reported a position in MGC Diagnostics Corporation in Q4 2017 and held it in 1 quarter.
  • K2 Principal Fund's MGC Diagnostics Corporation position peaked at $578K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.

Based on K2 Principal Fund's 13F filing for Q1 2018, filed 14 May 2018.